Prognostic factors of primary fallopian tube carcinoma

ArticleAçık Erişim

Özet

Aim of the study: Fallopian tube cancer is very rare in the literature and so there are not enough data about the therapeutic approaches. The approaches are generally determined in accordance with the data obtained from ovarian cancer. Many prognostic factors have been investigated in an effort to better estimate patient outcome. Stage, age, and residual tumor after surgery are consistently important prognostic factors. In this study, we aimed to evaluate the prognostic factors and survival rates of primary fallopian tube cancer (PFTC), which is rare among gynecological cancers. Material and methods: Thirty-eight patients with a diagnosis of PFTC were identified through the gynecologic oncology service database of our Research and Training Hospital in the period 1995-2013. Clinicopathological and surgical data were collected. All patients were evaluated for survival and disease-free survival between the dates specified. Results: A significant relationship and correlation was found between optimal surgery and life expectancy. Better results were obtained in patients treated with optimal surgery. The survival probability was found to be higher in patients with lower CA-125 levels and serous histologic type adenocarcinoma. Conclusions: Stage is one of the factors affecting the survival probability. We determined that the pathological type of tumor, the diameter of residual tumor remaining after surgery, tumor grade, preoperative CA-125 levels and presence of ascites affect the survival probability. © 2018 Taylor and Francis Ltd. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14245Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5114/wo.2017.69590Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkkaya, Emrah
dc.contributor.authorSanci, Muzaffer
dc.contributor.authorKulhan, Nur G.
dc.contributor.authorKulhan, Mehmet
dc.contributor.authorNayki, Umit
dc.contributor.authorNayki, Cenk
dc.contributor.authorAta, Nahit
dc.contributor.authorUlug, Pasa
dc.date.accessioned2026-10-18T20:29:02.357346823Z
dc.date.available2026-10-18T20:29:02.357346823Z
dc.date.issued2018
dc.description.abstractAim of the study: Fallopian tube cancer is very rare in the literature and so there are not enough data about the therapeutic approaches. The approaches are generally determined in accordance with the data obtained from ovarian cancer. Many prognostic factors have been investigated in an effort to better estimate patient outcome. Stage, age, and residual tumor after surgery are consistently important prognostic factors. In this study, we aimed to evaluate the prognostic factors and survival rates of primary fallopian tube cancer (PFTC), which is rare among gynecological cancers. Material and methods: Thirty-eight patients with a diagnosis of PFTC were identified through the gynecologic oncology service database of our Research and Training Hospital in the period 1995-2013. Clinicopathological and surgical data were collected. All patients were evaluated for survival and disease-free survival between the dates specified. Results: A significant relationship and correlation was found between optimal surgery and life expectancy. Better results were obtained in patients treated with optimal surgery. The survival probability was found to be higher in patients with lower CA-125 levels and serous histologic type adenocarcinoma. Conclusions: Stage is one of the factors affecting the survival probability. We determined that the pathological type of tumor, the diameter of residual tumor remaining after surgery, tumor grade, preoperative CA-125 levels and presence of ascites affect the survival probability. © 2018 Taylor and Francis Ltd. All rights reserved.
dc.identifier.doi10.5114/wo.2017.69590
dc.identifier.eissn1897-4309
dc.identifier.endpage104
dc.identifier.issn1428-2526
dc.identifier.issue2
dc.identifier.pmcidPMC6103229
dc.identifier.pmid30150886
dc.identifier.scopus2-s2.0-85050868283
dc.identifier.startpage99
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14245
dc.identifier.volume22
dc.identifier.wosWOS:000439064100005
dc.language.isoen
dc.publisherTermedia Publishing House Ltd.
dc.relation.ispartofWspolczesna Onkologia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectManagement
dc.subjectPrimary fallopian tube cancer
dc.subjectPrognostic factor
dc.subjectTreatment
dc.subjectCA 125 antigen
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectcancer staging
dc.subjectcancer surgery
dc.subjectclinical article
dc.subjectdisease free survival
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjecthysterectomy
dc.subjectlife expectancy
dc.subjectmenopause
dc.subjectoverall survival
dc.subjectprognosis
dc.subjectsalpingooophorectomy
dc.subjectsurvival rate
dc.subjectuterine tube carcinoma
dc.subjectvagina bleeding
dc.titlePrognostic factors of primary fallopian tube carcinoma
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus11
rdl.citation.wos10
rdl.departmentDepartment of Obstetrics and Gynecology, Erzincan University, School of Medicine, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)